Search research articles
Contact Us
Filters
Showing results (1591-1600 of 1,634) with videos related to
Page
of 164
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project
Lukas Bubendorf, Urania Dafni, Martin Schöbel, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib
Lei Wei, Song Liu, Jeffrey Conroy, et al.
Frontiers in Health Services
|
March 17, 2023
<i>STOP COVID-19 CA:</i> Community engagement to address the disparate impacts of the COVID-19 pandemic in California
Alejandra Casillas, Lisa G Rosas, Savanna L Carson, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization
Y M Choi-Sledeski, D G McGarry, D M Green, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
<i>PTPN11</i> Mutation Clonal Hierarchy in Acute Myeloid Leukemia
Sydney Fobare, Chia Sharpe, Kate Quinn, et al.
Journal of Medical Virology
|
May 29, 2009
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses
Ruth Harbecke, Michael N Oxman, Beth A Arnold, et al.
Science Translational Medicine
|
February 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1
Carl J Balibar, Daniel J Klein, Beata Zamlynny, et al.
Journal of Medicinal Chemistry
|
May 17, 2002
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity
T G Murali Dhar, Zhongqi Shen, Junqing Guo, et al.
Nature Cancer
|
March 19, 2021
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K Mehta, Emily M Cheney, Christina A Hartl, et al.
Human Molecular Genetics
|
November 28, 2012
GLRB is the third major gene of effect in hyperekplexia
Seo-Kyung Chung, Anna Bode, Thomas D Cushion, et al.
Page
of 164
Search research articles
Search
Showing results (1591-1600 of 1,634) with videos related to
Sort By:
Page
of 164
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project
Lukas Bubendorf, Urania Dafni, Martin Schöbel, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib
Lei Wei, Song Liu, Jeffrey Conroy, et al.
Frontiers in Health Services
|
March 17, 2023
<i>STOP COVID-19 CA:</i> Community engagement to address the disparate impacts of the COVID-19 pandemic in California
Alejandra Casillas, Lisa G Rosas, Savanna L Carson, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization
Y M Choi-Sledeski, D G McGarry, D M Green, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
<i>PTPN11</i> Mutation Clonal Hierarchy in Acute Myeloid Leukemia
Sydney Fobare, Chia Sharpe, Kate Quinn, et al.
Journal of Medical Virology
|
May 29, 2009
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses
Ruth Harbecke, Michael N Oxman, Beth A Arnold, et al.
Science Translational Medicine
|
February 22, 2023
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1
Carl J Balibar, Daniel J Klein, Beata Zamlynny, et al.
Journal of Medicinal Chemistry
|
May 17, 2002
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity
T G Murali Dhar, Zhongqi Shen, Junqing Guo, et al.
Nature Cancer
|
March 19, 2021
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K Mehta, Emily M Cheney, Christina A Hartl, et al.
Human Molecular Genetics
|
November 28, 2012
GLRB is the third major gene of effect in hyperekplexia
Seo-Kyung Chung, Anna Bode, Thomas D Cushion, et al.
Page
of 164